The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (30)
Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo
1995 • 1,039 citations
Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone Metastases
1996 • 1,023 citations
Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.
1991 • 1,013 citations
Breast Tumor Cell Lines From Pleural Effusions2
1974 • 973 citations
Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose.
1986 • 870 citations
Reduction in New Metastases in Breast Cancer with Adjuvant Clodronate Treatment
1998 • 811 citations
Pamidronate Reduces Skeletal Morbidity in Women With Advanced Breast Cancer and Lytic Bone Lesions: A Randomized, Placebo-Controlled Trial
1999 • 602 citations
Mechanism of Action
2002 • 434 citations
Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones.
1987 • 434 citations
Bisphosphonates induce apoptosis in human breast cancer cell lines
2000 • 430 citations
Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice.
1995 • 421 citations
Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti‐tumour activity
1997 • 408 citations
Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.
1998 • 373 citations
Protein Geranylgeranylation Is Required for Osteoclast Formation, Function, and Survival: Inhibition by Bisphosphonates and GGTI-298
2000 • 356 citations
Bisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matrices.
1997 • 349 citations
Adjuvant Clodronate Treatment Does Not Reduce the Frequency of Skeletal Metastases in Node-Positive Breast Cancer Patients: 5-Year Results of a Randomized Controlled Trial
2001 • 346 citations
Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro.
1996 • 306 citations
Bisphosphonates Induce Breast Cancer Cell Death In Vitro
2000 • 275 citations
In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonates
1998 • 265 citations
Bisphosphonates Act Directly on the Osteoclast to Induce Caspase Cleavage of Mst1 Kinase during Apoptosis
1999 • 253 citations
BM 21.0955, a potent new bisphosphonate to inhibit bone resorption
1991 • 247 citations
Histopathological Evaluation of Apoptosis in Cancer
1998 • 245 citations
Clodronate decreases the frequency of skeletal metastases in women with breast cancer
1996 • 226 citations
The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway.
1998 • 218 citations
Chapter 3 Assays for DNA Fragmentation, Endonucleases, and Intracellular pH and Ca2+ Associated with Apoptosis
1995 • 128 citations
Bone resorption induced by a metastatic human melanoma cell line
1995 • 54 citations
Use of bisphosphonates for the treatment of bone metastasis in experimental animal models
1999 • 53 citations
Stimulation of bone resorption results in a selective increase in the growth rate of spontaneously metastatic Walker 256 cancer cells in bone
1992 • 35 citations
Localization of parathyroid hormone-related protein in osteoclasts by in situ hybridization and immunohistochemistry
1998 • 30 citations
Drug disposition of incadronate, a new bisphosphonate, in rats with bone metastases
1997 • 13 citations